Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
952 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00471328 | Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib(ENEST) | completed | Phase 3 | 248 | Novartis PharmaceuticalsINDUSTRY | 13 | Jun 12, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 |
| clinicaltrials |
| NCT00420849 | A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma | completed | Phase 3 | 587 | Celgene CorporationINDUSTRY | 5 | May 21, 2012 | clinicaltrials |
| NCT00311467 | Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma | terminated | Phase 3 | 172 | Central European Cooperative Oncology GroupOTHER | 1 | May 16, 2012 | clinicaltrials |
| NCT00003215 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | completed | Phase 3 | 400 | Swiss Cancer InstituteOTHER | 5 | May 15, 2012 | clinicaltrials |
| NCT00294437 | ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases | terminated | Phase 3 | 376 | Central European Cooperative Oncology GroupOTHER | 16 | May 1, 2012 | clinicaltrials |
| NCT00379470 | Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM) | completed | Phase 3 | 236 | NovoCure Ltd.INDUSTRY | 7 | May 1, 2012 | clinicaltrials |
| NCT00911027 | SonoVue Guided Prostate Biopsy | terminated | Phase 3 | 282 | Bracco Diagnostics, IncINDUSTRY | 7 | Apr 25, 2012 | clinicaltrials |
| NCT00003279 | Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer(SILVA) | completed | Phase 3 | 500 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Mar 6, 2012 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 | clinicaltrials |
| NCT00283062 | Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy | completed | Phase 3 | 228 | SanofiINDUSTRY | 17 | Jan 26, 2012 | clinicaltrials |
| NCT00048230 | PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | completed | Phase 3 | 620 | Millennium Pharmaceuticals, Inc.INDUSTRY | 13 | Jan 13, 2012 | clinicaltrials |
| NCT00063726 | A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039 | completed | Phase 3 | 600 | Millennium Pharmaceuticals, Inc.INDUSTRY | 13 | Jan 13, 2012 | clinicaltrials |
| NCT00309556 | Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer | completed | Phase 3 | 536 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 30, 2011 | clinicaltrials |
| NCT00002763 | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,000 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 21 | Nov 16, 2011 | clinicaltrials |
| NCT00174655 | BIG 02/98 Docetaxel - Breast Cancer | completed | Phase 3 | 2,887 | SanofiINDUSTRY | 21 | Nov 10, 2011 | clinicaltrials |
| NCT00518895 | Trial of Dacarbazine With or Without Genasense in Advanced Melanoma(AGENDA) | completed | Phase 3 | 300 | Genta IncorporatedINDUSTRY | 12 | Nov 7, 2011 | clinicaltrials |
| NCT00122772 | CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy | completed | Phase 3 | 601 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 14, 2011 | clinicaltrials |
| NCT00921037 | First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas | unknown | Phase 2 / Phase 3 | 12 | Medical University of ViennaOTHER | 1 | Jul 13, 2011 | clinicaltrials |
| NCT00294385 | Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine | completed | Phase 3 | 430 | Central European Cooperative Oncology GroupOTHER | 7 | Jun 23, 2011 | clinicaltrials |
| NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Apr 18, 2011 | clinicaltrials |
| NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer(TAX316) | completed | Phase 3 | 1,491 | SanofiINDUSTRY | 20 | Feb 16, 2011 | clinicaltrials |
| NCT00941252 | ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial(ITIC) | completed | Phase 2 / Phase 3 | 60 | Medical University of ViennaOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00401323 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 / Phase 3 | 568 | SanofiINDUSTRY | 20 | Jan 20, 2011 | clinicaltrials |
| NCT00673205 | (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer(Capri) | completed | Phase 3 | 3,588 | AstraZenecaINDUSTRY | 16 | Dec 10, 2010 | clinicaltrials |
| NCT00715637 | Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study | unknown | Phase 3 | 420 | Antisoma ResearchINDUSTRY | 23 | Oct 13, 2010 | clinicaltrials |
| NCT00043134 | Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome | unknown | Phase 3 | 220 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Apr 13, 2010 | clinicaltrials |
| NCT00063141 | Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer | completed | Phase 3 | 1,302 | Eli Lilly and CompanyINDUSTRY | 17 | Apr 12, 2010 | clinicaltrials |
| NCT00143455 | Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer | completed | Phase 3 | 485 | PfizerINDUSTRY | 13 | Feb 18, 2010 | clinicaltrials |
| NCT00002549 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | unknown | Phase 3 | 1,520 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Dec 23, 2009 | clinicaltrials |
| NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 908 | Eli Lilly and CompanyINDUSTRY | 26 | Oct 28, 2009 | clinicaltrials |
| NCT00375076 | Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients | completed | Phase 3 | — | Medical University of ViennaOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00300508 | 3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer | completed | Phase 3 | 856 | AstraZenecaINDUSTRY | 1 | May 1, 2009 | clinicaltrials |
| NCT00275210 | MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer | completed | Phase 3 | 2,246 | SanofiINDUSTRY | 19 | Apr 20, 2009 | clinicaltrials |
| NCT00146120 | Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result | completed | Phase 3 | 400 | University of UlmOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00081796 | Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | completed | Phase 3 | 438 | SanofiINDUSTRY | 26 | Aug 21, 2008 | clinicaltrials |
| NCT00068952 | Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme | completed | Phase 3 | 118 | PfizerINDUSTRY | 13 | Apr 1, 2008 | clinicaltrials |
| NCT00128531 | Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer | completed | Phase 3 | 120 | GP-PharmINDUSTRY | 9 | Nov 14, 2007 | clinicaltrials |
| NCT00348738 | Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome | unknown | Phase 3 | 300 | Medical University of ViennaOTHER | 1 | Nov 2, 2007 | clinicaltrials |
| NCT00546988 | Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years | unknown | Phase 3 | 600 | University of WuerzburgOTHER | 2 | Oct 19, 2007 | clinicaltrials |
| NCT00036556 | Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 941 | AbbottINDUSTRY | 17 | Aug 15, 2007 | clinicaltrials |
| NCT00054795 | Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) | completed | Phase 3 | 550 | Pharmacyclics LLC.INDUSTRY | 8 | May 8, 2007 | clinicaltrials |
| NCT00161980 | Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites | completed | Phase 3 | — | Baxter Healthcare CorporationINDUSTRY | 4 | Oct 23, 2006 | clinicaltrials |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 1,000 | AbbottINDUSTRY | 18 | Aug 15, 2006 | clinicaltrials |
| NCT00035035 | A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 18 | Jul 19, 2006 | clinicaltrials |
| NCT00327262 | Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase | unknown | Phase 3 | 240 | Central European Leukemia Study GroupOTHER | 1 | Jun 20, 2006 | clinicaltrials |
| NCT00144079 | Multicenter Study Differentiated Thyroid Carcinoma | completed | Phase 3 | 500 | University Hospital MuensterOTHER | 3 | May 9, 2006 | clinicaltrials |
| NCT00309517 | Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C | terminated | Phase 3 | 700 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | completed | Phase 3 | 598 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00309543 | Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B | completed | Phase 3 | 636 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials